| Literature DB >> 6951603 |
M Housset, M T Daniel, L Degos.
Abstract
Three patients with acute myeloid leukaemia were treated with small doses of ARA-C (10 mg/m2/12 h, subcutaneous injections) and complete remission was obtained. The small doses of ARA-C, the progressive evolution, the absence of aplasia before remission, the simultaneous presence of normal islets of promyelocytes and leukaemic myeloblasts, favour a differentiating role for the drug rather than an antimitotic effect.Entities:
Mesh：
Substances：
Year: 1982 PMID： 6951603 DOI： 10.1111/j.1365-2141.1982.tb07297.x
Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998